1 / 6

United States Influenza Vaccine Market,Production, Distribution and Forecast to 2022

United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022.<br><br>Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine. <br><br>The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It provides essential insights into United States influenza vaccine market and forecast. It covers vaccination pattern, doses distribution, production and offers a clear view of the regulatory landscape. Additionally, the report includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details. <br><br>The report concludes with the profiles of major players in the influenza vaccine market such as Sanofi Pasteur, GSK, Seqirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period. The report also entails major drivers and barriers of influenza vaccine market. <br><br><br>Major and Promising Vaccine covered in the report are as follows:<br><br><br>1. Fluzone High–Dose<br>2. Fluzone Quadrivalent<br>3. Intradermal (ID) Trivalent <br>4. Vaxigrip <br>5. Fluarix Quadrivalent <br>6. Flulaval Quadrivalent<br>7. Fluenz Tetra <br>8. FluMist Quadrivalent <br>9. Flublok<br>10. VN–100<br>11. M–001 <br>12. VAX–2012Q <br>13. TAK – 850 <br>14. Flucelvax Quadrivalent <br>15. Afluria Quadrivalent<br>16. Agrippal<br>17. Fluad <br>18. Fluvirin<br>19. Fluvax <br><br>Key Companies Covered in the Report are as follows<br><br><br>1. Sanofi Pasteur <br>2. GlaxoSmithKline(GSK) <br>3. Seqirus<br>4. AstraZenecca <br>5. Protein Sciences Corporation<br>6. Novavax <br>7. Daiichi–Sankyo <br>8. Mitsubishi Tanabe Pharma <br>9. BiondVax Pharmaceuticals Ltd<br>10. VaxInnate<br><br>Contact Info:<br>Name: Maria Rai,Sales Manager<br>Email: sales@dpiresearch.com<br>Organization: DPI Research<br>Phone: 91 728-994-9987

dpiresearch
Télécharger la présentation

United States Influenza Vaccine Market,Production, Distribution and Forecast to 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. www.dpiresearch.com

  2. United States Influenza Vaccine Market Publish Date : 1 Publish Date : 1st stDecember 2016 December 2016 No. of Pages : 122 No. of Pages : 122 Geography Coverage : United States Geography Coverage : United States Price for Single User Licence : USD 1000 Price for Single User Licence : USD 1000 Price for Global User Licence : USD 1400 Price for Global User Licence : USD 1400 Delivery Time : Within 24 hours Delivery Time : Within 24 hours www.dpiresearch.com

  3. United States Influenza Vaccine Market United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022. Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine. www.dpiresearch.com

  4. United States Influenza Vaccine Market Report Coverage: 1. Executive Summary 2. United States Influenza Vaccine Market & Forecast 3. United States Number of Persons Vaccinated with Influenza Vaccine 4. United States Influenza Vaccine Market Drivers and Barriers 5. United Distribution States Influenza Vaccine Production & www.dpiresearch.com

  5. United States Influenza Vaccine Market Report Coverage Continues: 6. Regulatory Landscape United States Influenza Vaccine Market – 7. Market Dynamics – Mergers, Acquisitions, Key Agreements & Collaborations 8. Influenza Vaccine – Pipeline Assessment 9. Influenza Vaccine – Clinical Trials Assessment by Phase and Trial Status 10. Key Companies Analysis www.dpiresearch.com

  6. United States Influenza Vaccine Market How to Buy this Report? Visit following URL to see Table of Content and purchase this publication: http://www.dpiresearch.com/report-details.php?P_ID=88 Contact us: sales@dpiresearch.com For More Details visit: www.dpiresearch.com www.dpiresearch.com

More Related